DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Human cancers are characterized by genomic instability and elevated mutation rates.
• Defects in DNA repair pathways are a common hallmark of cancer cells.
• Six major DNA repair pathways are implicated: mismatch repair, base excision repair, nucleotide excision repair, homologous recombination, nonhomologous end joining, and translesion synthesis.

Purpose of the Study:

• To explore the role of DNA repair pathway defects in cancer development and progression.
• To investigate how specific DNA repair pathway deficiencies predict mutation types, drug sensitivity, and treatment outcomes.
• To highlight the utility of studying rare DNA repair disorders for understanding sporadic cancers and developing new therapies.

Main Methods:

• Review of existing literature on DNA repair pathways and their role in cancer.
• Analysis of how defects in specific DNA repair pathways influence genomic instability.
• Examination of insights gained from inherited DNA repair disorders, such as Fanconi anemia, applied to sporadic cancers.

Main Results:

• Defects in DNA repair pathways are fundamental to cancer's genomic instability.
• The specific defective pathway correlates with mutation profiles, tumor drug sensitivity, and patient outcomes.
• Fanconi anemia pathway deregulation exemplifies how DNA repair defects impact cancer.

Conclusions:

• Understanding DNA repair pathway integrity is crucial for guiding cancer management.
• Biomarkers for DNA repair pathway integrity can inform personalized cancer treatment strategies.
• Targeting or leveraging DNA repair pathways holds potential for novel cancer therapeutic development.